Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
A Agilent Technologies	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the recommendation accuracy rating	$127.07 -5.5%	$161.00 ➝ $159.00	Outperform ➝ Outperform
AAP Advance Auto Parts	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.96 -2.0%	$50.00 ➝ $44.00	Sector Perform ➝ Sector Perform
AAP Advance Auto Parts	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Ciccarelli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.96 -2.0%	$39.00 ➝ $34.00	Hold ➝ Hold
AAP Advance Auto Parts	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Zaccone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.96 -2.0%	$47.00 ➝ $40.00	Neutral ➝ Neutral
AAP Advance Auto Parts	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Thomas-Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.96 -2.0%	$45.00 ➝ $40.00	Market Perform ➝ Market Perform
ACAD ACADIA Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.34 +1.8%	$28.00 ➝ $28.00	Buy ➝ Buy
ACAD ACADIA Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.34 +1.8%	$27.00 ➝ $27.00	Buy ➝ Buy
ACAD ACADIA Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Duncan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.34 +1.8%	$28.00 ➝ $28.00	Overweight ➝ Overweight
ACET Adicet Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.86 -4.7%		Neutral ➝ Neutral
ACMR ACM Research	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.10 -5.7%		Hold ➝ Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADSK Autodesk	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$282.35 -1.2%	$361.00 ➝ $339.00	Buy ➝ Buy
ADUS Addus HomeCare	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tao Qiu Subscribe to MarketBeat All Access for the recommendation accuracy rating	$96.86 +1.2%	$129.00 ➝ $129.00	Outperform ➝ Outperform
AER AerCap	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Stathoulopoulos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$102.79 +0.4%	$108.00 ➝ $120.00	Positive ➝ Positive
AER AerCap	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Terry Ma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$102.79 +0.4%	$113.00 ➝ $115.00	Overweight ➝ Overweight
AGI Alamos Gold	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.69 -3.2%	C$35.00 ➝ C$39.00	Buy
AHCO AdaptHealth	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Coldwell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.09 -0.1%	$14.00 ➝ $16.00	Outperform ➝ Outperform
AI C3.ai	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Schreiner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%	$40.00 ➝ $25.00	Neutral ➝ Neutral
AI C3.ai	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%		Hold ➝ Hold
AI C3.ai	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arvind Ramnani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%	$42.00 ➝ $28.00	Neutral ➝ Neutral
AI C3.ai	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sanjit Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%	$32.00 ➝ $30.00	Underweight ➝ Underweight
AI C3.ai	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Heath Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%	$29.00 ➝ $21.00	Underweight ➝ Underweight
AI C3.ai	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.80 -10.0%	$40.00 ➝ $30.00	Hold ➝ Hold
ALEC Alector	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.66 -3.5%	$7.00 ➝ $7.00	Buy ➝ Buy
AMBA Ambarella	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.92 -17.0%	$95.00 ➝ $100.00	Buy ➝ Buy
AMBA Ambarella	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.92 -17.0%	$100.00 ➝ $110.00	Buy ➝ Buy
AMBA Ambarella	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.92 -17.0%	$100.00 ➝ $100.00	Buy ➝ Buy
APG APi Group	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Wittmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.83 -2.9%	$40.00 ➝ $46.00	Outperform ➝ Outperform
APG APi Group	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bibb Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.83 -2.9%	$45.00 ➝ $48.00	Buy ➝ Buy
APP AppLovin	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Brondolo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$320.49 -3.2%	$538.00	Overweight ➝ Overweight
ARDT Ardent Health Partners	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.10 +7.8%	$22.00 ➝ $22.00	Overweight ➝ Overweight
ARHS Arhaus	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.37 -14.4%	$15.00 ➝ $12.00	Overweight ➝ Neutral
ARHS Arhaus	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Benedict Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.37 -14.4%	$12.00 ➝ $13.00	Outperform ➝ Outperform
ARKO Arko	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.52 -37.7%	$8.50 ➝ $7.50	Buy ➝ Hold
ARQT Arcutis Biotherapeutics	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.80 -3.2%	$13.00 ➝ $15.00	Neutral ➝ Neutral
ASTE Astec Industries	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mircea Dobre Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.90 +1.2%	$40.00 ➝ $41.00	Neutral ➝ Neutral
ATD Alimentation Couche-Tard	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$70.63 +0.2%	C$85.00 ➝ C$84.00	Buy
ATEC Alphatec	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.12 +9.6%	$16.00 ➝ $16.00	Buy ➝ Buy
ATEC Alphatec	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt O'Brien Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.12 +9.6%	$12.00 ➝ $13.00	Overweight ➝ Overweight
ATXS Astria Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.31 -0.6%	$16.00 ➝ $16.00	Buy ➝ Buy
AVDX AvidXchange	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sanjay Sakhrani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$11.00 ➝ $8.00	Market Perform ➝ Market Perform
Warning: Elon’s $20k Robot Might Replace Your Nanny (Ad) Tesla’s Robot Revolution Has Begun It’s official… Tesla’s robot revolution is underway… By the end of this year, Tesla plans to produce 600 new “Tesla Bots” per week… Tech insiders believe this could be the company’s next core driver of explosive growth. Some even believe it could be the catalyst that would push shares above the $1,000 mark. That’s essentially a 100% increase from today’s price… just follow this link.
AVDX AvidXchange	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tien-Tsin Huang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$10.00 ➝ $9.00	Neutral ➝ Neutral
AVDX AvidXchange	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$11.00 ➝ $8.00	Equal Weight ➝ Equal Weight
AVDX AvidXchange	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$14.00 ➝ $12.00	Outperform ➝ Outperform
AVDX AvidXchange	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$9.50 ➝ $7.00	Sell ➝ Sell
AVDX AvidXchange	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rufus Hone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$11.00 ➝ $7.50	Market Perform ➝ Market Perform
AVDX AvidXchange	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Bauch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%	$10.00 ➝ $8.00	Equal Weight ➝ Equal Weight
AVDX AvidXchange	Downgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Markgraff Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.36 +1.4%		Overweight ➝ Sector Weight
AWI Armstrong World Industries	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$151.21 -0.7%	$162.00 ➝ $175.00	Buy ➝ Buy
AXON Axon Enterprise	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the recommendation accuracy rating	$525.63 -8.2%	$585.00 ➝ $726.00	Overweight ➝ Overweight
AXSM Axsome Therapeutics	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vikram Purohit Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.41 -1.5%	$125.00 ➝ $190.00	Overweight ➝ Overweight
BASE Couchbase	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.53 -4.0%	$18.00 ➝ $16.00	Sell ➝ Sell
BATRA Atlanta Braves	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Harrigan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.30 +0.4%	$60.00 ➝ $60.00	Buy ➝ Buy
BBVA Banco Bilbao Vizcaya Argentaria	Upgraded by	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.29 -1.0%		Reduce ➝ Hold
BBWI Bath & Body Works	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.95 -12.5%	$43.00 ➝ $43.00	Outperform ➝ Outperform
BBWI Bath & Body Works	Reiterated by	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.95 -12.5%		Buy ➝ Buy
BBY Best Buy	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$88.61 -2.0%	$110.00 ➝ $110.00	Outperform ➝ Outperform
BEAM Beam Therapeutics	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Debjit Chattopadhyay Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.11 -2.8%	$78.00 ➝ $78.00	Buy ➝ Buy
BLD TopBuild	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Stevenson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$304.01 -0.3%	$405.00 ➝ $390.00	Buy ➝ Buy
BLD TopBuild	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$304.01 -0.3%	$395.00 ➝ $310.00	Hold ➝ Hold
BLMN Bloomin' Brands	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Cho Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.00 +1.0%	$13.00 ➝ $10.00	Sell ➝ Sell
BLMN Bloomin' Brands	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Strelzik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.00 +1.0%	$16.00 ➝ $12.00	Market Perform ➝ Market Perform
BLMN Bloomin' Brands	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.00 +1.0%	$13.00 ➝ $11.00	Equal Weight ➝ Equal Weight
BRDG Bridge Investment Group	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Brown Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.38 -0.5%	$10.00 ➝ $11.50	Overweight ➝ Equal Weight
BSY Bentley Systems	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.04 -1.3%		Outperform ➝ Market Perform
BSY Bentley Systems	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.04 -1.3%	$60.00 ➝ $59.00	Outperform ➝ Outperform
BURL Burlington Stores	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$242.06 -2.9%	$340.00 ➝ $340.00	Outperform ➝ Outperform
BXSL Blackstone Secured Lending Fund	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Lynch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.16 +1.3%	$30.50 ➝ $32.00	Market Perform ➝ Market Perform
BXSL Blackstone Secured Lending Fund	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.16 +1.3%	$33.00 ➝ $35.00	Buy ➝ Buy
BYND Beyond Meat	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Strelzik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.18 -10.7%	$6.00 ➝ $5.00	Market Perform ➝ Market Perform
BYND Beyond Meat	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.18 -10.7%	$4.00 ➝ $3.00	Underweight ➝ Underweight
CALM Cal-Maine Foods	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Sharma Subscribe to MarketBeat All Access for the recommendation accuracy rating	$88.78 +1.0%	$97.00 ➝ $97.00	Equal Weight ➝ Equal Weight
CART Maplebear	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Compton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.74 -4.8%	$52.00 ➝ $55.00	Outperform ➝ Outperform
CAVA CAVA Group	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alton Stump Subscribe to MarketBeat All Access for the recommendation accuracy rating	$90.02 -9.0%	$147.00 ➝ $100.00	Hold ➝ Hold
CBZ CBIZ	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.12 -3.4%		Outperform
CDNA CareDx	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mason Carrico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.06 -0.2%	$40.00 ➝ $40.00	Overweight ➝ Overweight
CERT Certara	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.40 +0.6%	$17.00 ➝ $17.00	Overweight ➝ Overweight
CERT Certara	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.40 +0.6%		Market Perform
CERT Certara	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.40 +0.6%	$16.00	Buy
CHKP Check Point Software Technologies	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Dezort Subscribe to MarketBeat All Access for the recommendation accuracy rating	$216.69 -1.9%		Hold ➝ Hold
CHKP Check Point Software Technologies	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the recommendation accuracy rating	$216.69 -1.9%	$235.00 ➝ $255.00	Neutral ➝ Outperform
CHKP Check Point Software Technologies	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$216.69 -1.9%	$250.00 ➝ $255.00	Buy ➝ Buy
CHKP Check Point Software Technologies	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$216.69 -1.9%	$215.00 ➝ $215.00	Sector Perform ➝ Sector Perform
CLF Cleveland-Cliffs	Target Lowered by	Glj Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.70 +1.2%	$14.54 ➝ $12.90	Buy ➝ Buy
CMPS COMPASS Pathways	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Matteis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.92 +5.9%	$11.00	Buy
CMTG Claros Mortgage Trust	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jade Rahmani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.29 -8.2%	$4.00 ➝ $2.50	Underperform ➝ Underperform
COCO Vita Coco	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.21 -4.4%	$40.00 ➝ $39.00	Overweight ➝ Overweight
COCO Vita Coco	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bonnie Herzog Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.21 -4.4%	$34.00 ➝ $38.00	Buy ➝ Buy
COGT Cogent Biosciences	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joel Beatty Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.99 +4.2%	$10.00 ➝ $8.00	Neutral ➝ Neutral
COMM CommScope	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Niknam Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.29 +1.9%	$7.00	Hold ➝ Hold
CORT Corcept Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.85 -5.6%	$115.00 ➝ $115.00	Buy ➝ Buy
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th.
CORT Corcept Therapeutics	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.85 -5.6%	$67.00 ➝ $78.00	Overweight ➝ Overweight
CORZ Core Scientific	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Todaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.71 +6.9%	$18.00 ➝ $17.00	Buy ➝ Buy
CORZ Core Scientific	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Dede Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.71 +6.9%	$17.00 ➝ $17.00	Buy ➝ Buy
CORZ Core Scientific	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.71 +6.9%	$17.00 ➝ $17.00	Buy ➝ Buy
CORZ Core Scientific	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.71 +6.9%	$24.00 ➝ $21.00	Overweight ➝ Overweight
CPNG Coupang	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jiong Shao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.75 -5.0%	$34.00 ➝ $35.00	Overweight ➝ Overweight
CPRX Catalyst Pharmaceuticals	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Loganathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.66 +5.2%	$33.00 ➝ $33.00	Overweight ➝ Overweight
CPX Capital Power	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$50.65 -1.1%	C$68.00 ➝ C$64.00	Market Perform
CPX Capital Power	Target Lowered by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$50.65 -1.1%	C$63.00 ➝ C$62.00	Sector Perform
CRM Salesforce	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$375.00 ➝ $367.00	Outperform ➝ Outperform
CRM Salesforce	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$440.00 ➝ $400.00	Buy ➝ Buy
CRM Salesforce	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$405.00 ➝ $400.00	Overweight ➝ Overweight
CRM Salesforce	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$345.00 ➝ $310.00	Equal Weight ➝ Equal Weight
CRM Salesforce	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$415.00 ➝ $380.00	Outperform ➝ Outperform
CRM Salesforce	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$400.00 ➝ $400.00	Buy ➝ Buy
CRM Salesforce	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$430.00 ➝ $400.00	Outperform ➝ Outperform
CRM Salesforce	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$415.00 ➝ $400.00	Buy ➝ Buy
CRM Salesforce	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yun Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$330.00 ➝ $300.00	Hold ➝ Hold
CRM Salesforce	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$425.00 ➝ $375.00	Buy ➝ Buy
CRM Salesforce	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$300.00 ➝ $275.00	Neutral ➝ Neutral
CRM Salesforce	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$247.00 ➝ $247.00	Sell ➝ Sell
CRM Salesforce	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$440.00 ➝ $400.00	Sector Outperform ➝ Sector Outperform
CRM Salesforce	Target Lowered by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$294.80 -4.1%	$370.00 ➝ $320.00	Neutral ➝ Neutral
CRM Salesforce	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$294.80 -4.1%		Cautious ➝ Cautious
CRWD CrowdStrike	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$380.24 -3.6%	$385.00 ➝ $450.00	Buy ➝ Buy
CSCO Cisco Systems	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Malik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.81 -0.4%	$71.00 ➝ $73.00	Buy ➝ Buy
CTRI Centuri	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Hauke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.80 -3.8%	$23.00 ➝ $22.00	Outperform ➝ Outperform
CX CEMEX	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bruno Amorim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.31 -2.4%	$8.00 ➝ $9.00	Buy ➝ Buy
DBD Diebold Nixdorf	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Summerville Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.12 -3.2%	$65.00 ➝ $80.00	Buy ➝ Buy
DMRC Digimarc	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Reilly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.49 -42.7%	$40.00 ➝ $30.00	Buy ➝ Buy
DNTL dentalcorp	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$8.11 +1.6%	C$15.00	Buy
DTM DT Midstream	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Selman Akyol Subscribe to MarketBeat All Access for the recommendation accuracy rating	$92.92 -2.1%	$106.00 ➝ $102.00	Buy ➝ Buy
DY Dycom Industries	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the recommendation accuracy rating	$162.11 +0.1%	$229.00 ➝ $201.00	Overweight ➝ Overweight
EBAY eBay	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Pitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$59.00 ➝ $63.00	Market Perform ➝ Market Perform
EBAY eBay	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Mathivanan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$65.00 ➝ $70.00	Neutral ➝ Neutral
EBAY eBay	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Post Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$72.00 ➝ $71.00	Neutral ➝ Neutral
EBAY eBay	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$61.00 ➝ $64.00	Equal Weight ➝ Equal Weight
EBAY eBay	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Doug Anmuth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$58.00 ➝ $60.00	Neutral ➝ Neutral
EBAY eBay	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Mcternan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$72.00 ➝ $72.00	Buy ➝ Buy
EBAY eBay	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$65.00 ➝ $75.00	Buy ➝ Buy
EBAY eBay	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Kelley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$64.00 ➝ $63.00	Hold ➝ Hold
EBAY eBay	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$63.48 -8.2%	$64.00 ➝ $72.00	Overweight ➝ Overweight
ECPG Encore Capital Group	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.95 -21.9%	$64.00 ➝ $57.00	Buy ➝ Buy
EDV Endeavour Mining	Downgraded by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$28.72 -6.0%	C$41.00 ➝ C$37.00	Outperform ➝ Neutral
EFN Element Fleet Management	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$28.72 -1.0%	C$41.00 ➝ C$40.00	Outperform
EME EMCOR Group	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Brophy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$402.58 -4.3%	$600.00 ➝ $514.00	Buy ➝ Buy
ENOV Enovis	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.16 -4.6%	$65.00 ➝ $64.00	Buy ➝ Buy
EPR EPR Properties	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simon Yarmak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.06 +1.5%	$51.00 ➝ $52.00	Hold ➝ Hold
EQB EQB	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Young Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$101.27 -1.9%	C$130.00 ➝ C$126.00	Buy
EQB EQB	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$101.27 -1.9%	C$153.00 ➝ C$147.00	Outperform
Have you tried trading during the closing hour? (Ad) The opening (9:30 to 10:30) & closing hour (3:00 to 4:00) are the two most active periods of the trading day. More transactions happen within these two hours than all the others combined. But while many gurus recommend trading within the opening hour - as they should, since it's the most liquid... The closing hour doesn't get as much love. Which is odd, because this is exactly when major financial institutions enter the market to close their books for the day… Opening the door for smarter trading opportunities! Calling “the closing hour” the stock market's "Rush hour" won't be far from the truth. Go here now to learn all about them!
ESE ESCO Technologies	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tommy Moll Subscribe to MarketBeat All Access for the recommendation accuracy rating	$160.68 -1.0%	$175.00 ➝ $175.00	Overweight ➝ Overweight
ESTA Establishment Labs	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Carrico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.69 +18.4%	$52.00 ➝ $52.00	Overweight ➝ Overweight
EVTC EVERTEC	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.50 +16.0%		Outperform
EVTC EVERTEC	Upgraded by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Friedman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.50 +16.0%	$28.00 ➝ $30.00	Negative ➝ Neutral
EXE Chesapeake Energy	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.76 -4.6%	$128.00 ➝ $132.00	Outperform
EXLS ExlService	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.43 -0.4%	$50.00 ➝ $60.00	Buy ➝ Buy
EXLS ExlService	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.43 -0.4%	$48.00 ➝ $54.00	Buy ➝ Buy
EXR Extra Space Storage	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Heffern Subscribe to MarketBeat All Access for the recommendation accuracy rating	$153.50 -0.3%	$167.00 ➝ $163.00	Sector Perform ➝ Sector Perform
EYE National Vision	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.37 -3.1%	$12.00 ➝ $13.00	Equal Weight ➝ Equal Weight
FBLG FibroBiologics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.19 +4.4%	$16.00 ➝ $16.00	Buy ➝ Buy
FCX Freeport-McMoRan	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris LaFemina Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.35 -1.6%	$40.00 ➝ $48.00	Hold ➝ Buy
FIZZ National Beverage	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.58 -1.6%	$46.00 ➝ $41.00	Sell ➝ Sell
FLR Fluor	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Seiden Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.32 -1.0%	$45.00 ➝ $40.00	Equal Weight ➝ Equal Weight
FOUR Shift4 Payments	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the recommendation accuracy rating	$97.50 +1.1%	$109.00 ➝ $107.00	Equal Weight ➝ Equal Weight
FSLR First Solar	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.18 -10.0%	$335.00 ➝ $304.00	Buy ➝ Buy
FSLR First Solar	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Percoco Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.18 -10.0%	$297.00 ➝ $238.00	Overweight ➝ Overweight
FSLR First Solar	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$141.18 -10.0%	$265.00
FSZ Fiera Capital	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.40 -1.8%	C$8.50 ➝ C$6.50	Hold
FSZ Fiera Capital	Upgraded by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.40 -1.8%	C$8.50 ➝ C$7.00	Underperform ➝ Sector Perform
FSZ Fiera Capital	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.40 -1.8%	C$9.00 ➝ C$6.75	Neutral
FSZ Fiera Capital	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.40 -1.8%	C$10.00 ➝ C$8.75	Sector Perform
FSZ Fiera Capital	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.40 -1.8%	C$9.00 ➝ C$7.25	Hold
FWRD Forward Air	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Hartford Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.00 -10.7%	$32.00 ➝ $28.00	Neutral ➝ Neutral
GB Global Blue Group	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.32 -0.3%		Outperform ➝ Market Perform
GERN Geron	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.74 +8.1%	$3.50 ➝ $2.00	Buy ➝ Neutral
GERN Geron	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.74 +8.1%	$7.00 ➝ $5.00	Buy ➝ Buy
GERN Geron	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Willey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.74 +8.1%	$8.00 ➝ $4.00	Buy ➝ Buy
GERN Geron	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.74 +8.1%	$6.00 ➝ $4.00	Sector Outperform ➝ Sector Outperform
GERN Geron	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Lawson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.74 +8.1%	$9.00 ➝ $4.00	Overweight ➝ Overweight
GHRS GH Research	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Matteis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.65 -2.9%	$18.00 ➝ $32.00	Buy ➝ Buy
GO Grocery Outlet	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.83 +7.6%	$14.00 ➝ $11.00	Sell ➝ Sell
GOVX GeoVax Labs	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.44 -2.7%	$18.00 ➝ $18.00	Buy ➝ Buy
GS The Goldman Sachs Group	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$607.99 -1.6%	$690.00 ➝ $660.00	Outperform ➝ Market Perform
HASI Hannon Armstrong Sustainable Infrastructure Capital	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.50 -1.0%	$33.00	Overweight
HCAT Health Catalyst	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sean Dodge Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.30 -13.0%	$7.00 ➝ $6.00	Sector Perform ➝ Sector Perform
HCAT Health Catalyst	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.30 -13.0%	$7.00 ➝ $7.00	Equal Weight ➝ Equal Weight
HCAT Health Catalyst	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.30 -13.0%	$10.00 ➝ $5.00	Hold ➝ Hold
HE Hawaiian Electric Industries	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Reeder Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.72 -0.6%	$11.00 ➝ $12.50	Equal Weight ➝ Equal Weight
HG Hamilton Insurance Group	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.30 +4.8%	$24.00 ➝ $25.00	Overweight ➝ Overweight
HNST Honest	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.01 -11.8%	$7.00 ➝ $7.00	Market Perform ➝ Market Perform
HRMY Harmony Biosciences	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Trucchio Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.75 -2.2%	$75.00 ➝ $70.00	Buy ➝ Buy
HUMA Humacyte	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bruce Jackson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.37 -1.7%		Buy ➝ Buy
HURN Huron Consulting Group	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Steinke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$149.58 +0.9%	$142.00 ➝ $167.00	Outperform ➝ Outperform
ICL ICL Group	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joel Jackson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.15 +2.8%	$6.00 ➝ $6.50	Market Perform ➝ Market Perform
IGIC International General Insurance	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Heleniak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.47 -4.2%	$28.00 ➝ $31.00	Outperform ➝ Outperform
IGIC International General Insurance	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Phillips Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.47 -4.2%	$30.00 ➝ $32.00	Outperform ➝ Outperform
IMCR Immunocore	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.58 -3.9%	$71.00 ➝ $71.00	Buy ➝ Buy
IMNN Imunon	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.81 +0.7%	$29.00 ➝ $29.00	Buy ➝ Buy
INSW International Seaways	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Omar Nokta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.83 -7.2%	$58.00 ➝ $58.00	Buy ➝ Buy
INTU Intuit	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$600.42 -4.0%	$700.00 ➝ $600.00	Sector Perform ➝ Sector Perform
Most traders refer to weekends as dead days… (Ad) Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget... you can get the full story here
INVZ Innoviz Technologies	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.73 -5.9%	$4.00 ➝ $4.00	Buy ➝ Buy
IONQ IonQ	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.91 -16.8%	$54.00 ➝ $54.00	Buy ➝ Buy
IONQ IonQ	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.91 -16.8%	$50.00 ➝ $45.00	Buy ➝ Buy
IPAR Inter Parfums	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$140.29 -2.9%	$158.00 ➝ $168.00	Buy ➝ Buy
IPAR Inter Parfums	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Linda Bolton Weiser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$140.29 -2.9%	$163.00 ➝ $170.00	Buy ➝ Buy
IRON Disc Medicine	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.50 +0.1%		Buy
ITRI Itron	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the recommendation accuracy rating	$106.89 -0.8%	$135.00 ➝ $133.00	Buy ➝ Buy
ITRI Itron	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kashy Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$106.89 -0.8%	$119.00 ➝ $124.00	Neutral ➝ Neutral
ITRN Ituran Location and Control	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tavy Rosner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.78 -2.6%	$35.00 ➝ $50.00	Overweight ➝ Overweight
JACK Jack in the Box	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregory Francfort Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.62 +1.8%	$55.00 ➝ $55.00	Buy ➝ Buy
JAZZ Jazz Pharmaceuticals	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Balaji Prasad Subscribe to MarketBeat All Access for the recommendation accuracy rating	$143.27 -0.6%	$190.00 ➝ $200.00	Overweight ➝ Overweight
JOBY Joby Aviation	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Pierce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.77 +1.0%	$10.00 ➝ $10.00	Buy ➝ Buy
JOBY Joby Aviation	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bill Peterson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.77 +1.0%	$6.00 ➝ $5.00	Underweight ➝ Underweight
JOBY Joby Aviation	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.77 +1.0%	$9.00 ➝ $9.00	Buy ➝ Buy
JOBY Joby Aviation	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.77 +1.0%	$9.00 ➝ $9.00	Overweight ➝ Overweight
KDP Keurig Dr Pepper	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.60 -0.4%	$39.00
KEYS Keysight Technologies	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Eastman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$158.38 -1.2%	$180.00 ➝ $190.00	Outperform ➝ Outperform
KRC Kilroy Realty	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.52 +2.8%	$42.00 ➝ $44.00	Equal Weight ➝ Overweight
KROS Keros Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tiago Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.01 +0.6%	$28.00 ➝ $26.00	Overweight ➝ Overweight
KROS Keros Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.01 +0.6%	$47.00 ➝ $40.00	Buy ➝ Buy
KTOS Kratos Defense & Security Solutions	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Seth Seifman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.27 +5.2%	$24.00 ➝ $27.00	Neutral ➝ Neutral
KTOS Kratos Defense & Security Solutions	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.27 +5.2%	$37.00 ➝ $32.00	Outperform ➝ Outperform
KURA Kura Oncology	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.65 -1.5%	$36.00	Outperform
KURA Kura Oncology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.65 -1.5%	$40.00 ➝ $40.00	Buy ➝ Buy
LAB Standard BioTools	Downgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Knight Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.05 -10.7%		Overweight ➝ Sector Weight
LCID Lucid Group	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.23 -1.3%	$3.50 ➝ $3.00	Hold ➝ Hold
LINE Lineage	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Goldfarb Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.66 +4.4%	$90.00 ➝ $75.00	Overweight ➝ Overweight
LINE Lineage	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nicholas Thillman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.66 +4.4%	$76.00 ➝ $70.00	Outperform ➝ Outperform
LNF Leon's Furniture	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Conrad Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$24.20 -1.9%	C$32.00 ➝ C$31.00	Outperform
LNTH Lantheus	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$91.49 -1.9%	$120.00 ➝ $127.00	Buy ➝ Buy
LOW Lowe's Companies	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$245.87 -0.5%	$292.00 ➝ $285.00	Sector Perform ➝ Sector Perform
LOW Lowe's Companies	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Elizabeth Suzuki Subscribe to MarketBeat All Access for the recommendation accuracy rating	$245.87 -0.5%	$305.00 ➝ $290.00	Buy ➝ Buy
LOW Lowe's Companies	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Bellinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$245.87 -0.5%	$305.00 ➝ $300.00	Outperform ➝ Outperform
LOW Lowe's Companies	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$245.87 -0.5%	$307.00 ➝ $296.00	Overweight ➝ Overweight
LOW Lowe's Companies	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$245.87 -0.5%	$308.00 ➝ $295.00	Buy ➝ Buy
LPTH LightPath Technologies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.23 -2.6%	$5.00 ➝ $5.00	Buy ➝ Buy
LUG Lundin Gold	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$40.22 -3.5%	C$40.00 ➝ C$46.00	Buy
LVTX LAVA Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arthur He Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.29 -4.4%	$2.00 ➝ $1.50	Buy ➝ Neutral
LZ LegalZoom.com	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mario Lu Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.02 +13.2%	$8.00 ➝ $9.00	Equal Weight ➝ Equal Weight
LZ LegalZoom.com	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Sheldon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.02 +13.2%		Market Perform
M Macy's	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.11 -2.8%	$17.00 ➝ $17.00	Market Perform ➝ Market Perform
MARA MARA	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Todaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.13 +5.5%		Hold ➝ Hold
MARA MARA	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Dede Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.13 +5.5%	$28.00 ➝ $28.00	Buy ➝ Buy
MCS Marcus	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Goss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.57 -11.0%	$27.00 ➝ $27.00	Outperform ➝ Outperform
MDGL Madrigal Pharmaceuticals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Lebovitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$335.74 -5.7%	$378.00 ➝ $469.00	Buy ➝ Buy
MDGL Madrigal Pharmaceuticals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ed Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$335.74 -5.7%	$400.00 ➝ $405.00	Buy ➝ Buy
MDXG MiMedx Group	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Osborn Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.14 +1.6%	$13.00 ➝ $13.00	Overweight ➝ Overweight
MFIC MidCap Financial Investment	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Finian O'Shea Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.71 -0.3%	$15.00 ➝ $14.00	Overweight ➝ Overweight
MGNI Magnite	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.55 -1.8%	$20.00 ➝ $20.00	Buy ➝ Buy
MGNI Magnite	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.55 -1.8%	$16.00 ➝ $22.00	Positive ➝ Positive
MGNI Magnite	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.55 -1.8%	$21.00 ➝ $25.00	Buy ➝ Buy
MGPI MGP Ingredients	Upgraded by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Klieve Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.26 +3.2%	$55.00 ➝ $45.00	Hold ➝ Buy
MIRM Mirum Pharmaceuticals	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Skorney Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.97 -7.0%	$50.00 ➝ $55.00	Outperform ➝ Outperform
MLTX MoonLake Immunotherapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.77 -1.4%	$100.00 ➝ $100.00	Buy ➝ Buy
MLTX MoonLake Immunotherapeutics	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.77 -1.4%	$62.00 ➝ $66.00	Buy ➝ Buy
MLTX MoonLake Immunotherapeutics	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Law Subscribe to MarketBeat All Access for the recommendation accuracy rating	$41.77 -1.4%	$82.00 ➝ $73.00	Buy ➝ Buy
MMM 3M	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Deane Dray Subscribe to MarketBeat All Access for the recommendation accuracy rating	$150.48 +2.1%	$96.00 ➝ $96.00	Underperform ➝ Underperform
MNKD MannKind	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Zhong Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.23 -4.4%	$11.00	Outperform
MNRO Monro	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Wendler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.67 -4.2%	$21.00 ➝ $21.00	Equal Weight ➝ Equal Weight
MQ Marqeta	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.25 +21.1%	$4.00 ➝ $4.50	Neutral ➝ Neutral
MRP Millrose Properties	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Julien Blouin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.62 +1.7%	$25.00	Buy
MYRG MYR Group	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Hauke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.00 -4.7%	$201.00 ➝ $159.00	Outperform ➝ Outperform
NA National Bank of Canada	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$120.01 -0.4%	C$145.00 ➝ C$144.00	Sector Perform
NA National Bank of Canada	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$120.01 -0.4%	C$140.00 ➝ C$136.00	Hold
NA National Bank of Canada	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$120.01 -0.4%	C$135.00 ➝ C$131.00	Hold
NA National Bank of Canada	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$120.01 -0.4%	C$149.00 ➝ C$147.00	Buy
NA National Bank of Canada	Target Lowered by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Persaud Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$120.01 -0.4%	C$139.00 ➝ C$137.00
NA National Bank of Canada	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$120.01 -0.4%	C$143.00 ➝ C$135.00	Outperform
NAMS NewAmsterdam Pharma	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Belanger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.91 +6.1%	$46.00 ➝ $42.00	Buy ➝ Buy
NAMS NewAmsterdam Pharma	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Farmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.91 +6.1%	$47.00 ➝ $52.00	Sector Outperform ➝ Sector Outperform
NGD New Gold	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.70 -4.6%	$3.60 ➝ $3.40	Outperform
NRG NRG Energy	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shahriar Pourreza Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.05 -7.3%	$134.00 ➝ $145.00	Buy ➝ Buy
NRG NRG Energy	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Neil Kalton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$105.05 -7.3%	$140.00 ➝ $165.00	Overweight ➝ Overweight
NTNX Nutanix	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$83.00 ➝ $95.00	Outperform ➝ Outperform
NTNX Nutanix	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Hickey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$81.00 ➝ $91.00	Buy ➝ Buy
NTNX Nutanix	Upgraded by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.54 +10.4%	$77.00 ➝ $97.00	Market Perform ➝ Outperform
NTNX Nutanix	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$90.00 ➝ $92.00	Buy ➝ Buy
NTNX Nutanix	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$75.00 ➝ $85.00	Equal Weight ➝ Equal Weight
NTNX Nutanix	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Pinjalim Bora Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$83.00 ➝ $90.00	Overweight ➝ Overweight
NTNX Nutanix	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$83.00 ➝ $88.00	Overweight ➝ Overweight
NTNX Nutanix	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Param Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$90.00 ➝ $100.00	Outperform ➝ Outperform
NTNX Nutanix	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.54 +10.4%	$87.00 ➝ $94.00	Overweight ➝ Overweight
NTNX Nutanix	Target Set by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.54 +10.4%	$83.00
NVDA NVIDIA	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Prisco Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$200.00 ➝ $200.00	Overweight ➝ Overweight
NVDA NVIDIA	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$135.00 ➝ $135.00	Neutral ➝ Neutral
NVDA NVIDIA	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$190.00 ➝ $190.00	Buy ➝ Buy
NVDA NVIDIA	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$204.00 ➝ $205.00	Buy ➝ Buy
NVDA NVIDIA	Downgraded by	Summit Insights Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.15 -8.5%		Buy ➝ Hold
NVDA NVIDIA	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$190.00 ➝ $200.00	Buy ➝ Buy
NVDA NVIDIA	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.15 -8.5%	$160.00 ➝ $160.00	Buy ➝ Buy
NXST Nexstar Media Group	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Goss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$162.58 +11.1%	$200.00 ➝ $200.00	Outperform ➝ Outperform
ODD Oddity Tech	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.11 -0.5%	$50.00 ➝ $58.00	Buy ➝ Buy
ODD Oddity Tech	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lauren Lieberman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$45.11 -0.5%	$42.00 ➝ $46.00	Equal Weight ➝ Equal Weight
OLN Olin	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.07 -2.8%	$50.00 ➝ $28.00	Overweight ➝ Neutral
OLN Olin	Target Set by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.07 -2.8%	$28.00
ON Onsemi	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.38 -6.3%	$49.00 ➝ $49.00	Neutral ➝ Neutral
OPCH Option Care Health	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.20 +0.2%	$33.00 ➝ $38.00	Outperform ➝ Outperform
OR Osisko Gold Royalties	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tanya Jakusconek Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.94 -3.8%	$31.00 ➝ $22.00	Sector Perform ➝ Sector Perform
OSBC Old Second Bancorp	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Mcgratty Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.17 +0.2%	$22.00 ➝ $24.00	Outperform ➝ Outperform
PAAS Pan American Silver	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Hutchison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.93 -4.3%	$25.00 ➝ $28.00	Buy ➝ Buy
PARA Paramount Global	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.24 +0.2%	$14.00 ➝ $14.00	Buy ➝ Buy
PARA Paramount Global	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Kurnos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.24 +0.2%	$19.00 ➝ $19.00	Buy ➝ Buy
PARA Paramount Global	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.24 +0.2%		Hold ➝ Hold
PARR Par Pacific	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.12 +1.3%	$21.00 ➝ $17.00	Buy
PARR Par Pacific	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Neil Mehta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.12 +1.3%	$20.00 ➝ $18.00	Neutral ➝ Neutral
PBH Premium Brands	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$79.48 -0.6%	C$99.00 ➝ C$96.00	Sector Perform
PEB Pebblebrook Hotel Trust	Target Set by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.22 +4.0%	$14.00	Outperform ➝ Outperform
PLBC Plumas Bancorp	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Clark Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.63 +1.2%	$60.00	Overweight
PLNT Planet Fitness	Target Lowered by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Golding Subscribe to MarketBeat All Access for the recommendation accuracy rating	$91.56 +1.0%	$99.00 ➝ $95.00	Neutral ➝ Neutral
PLNT Planet Fitness	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$91.56 +1.0%	$105.00 ➝ $105.00	Buy ➝ Buy
POW Power Co. of Canada	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$48.62 +0.6%	C$52.00 ➝ C$54.00	Buy
PRKS United Parks & Resorts	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Chaiken Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.48 -6.4%	$43.00 ➝ $45.00	Underperform ➝ Underperform
PRKS United Parks & Resorts	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Curry Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.48 -6.4%	$70.00 ➝ $72.00	Buy ➝ Buy
PSTG Pure Storage	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Asiya Merchant Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.04 -15.1%	$80.00 ➝ $77.00	Buy ➝ Buy
PSTG Pure Storage	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.04 -15.1%	$47.00 ➝ $50.00	Sell ➝ Sell
PSTG Pure Storage	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.04 -15.1%	$77.00 ➝ $73.00	Neutral ➝ Neutral
PSTG Pure Storage	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.04 -15.1%	$75.00 ➝ $75.00	Buy ➝ Buy
PZZA Papa Johns International	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jim Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating	$46.89 +1.4%	$60.00 ➝ $60.00	Overweight ➝ Overweight
RLAY Relay Therapeutics	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bradley Canino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.25 -13.3%	$27.00 ➝ $23.00	Buy ➝ Buy
RLAY Relay Therapeutics	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Richter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.25 -13.3%	$20.00 ➝ $18.00	Buy ➝ Buy
ROOT Root	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Elyse Greenspan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.95 +25.6%	$80.00 ➝ $97.00	Equal Weight ➝ Equal Weight
RPAY Repay	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.21 +0.4%	$14.00 ➝ $14.00	Buy ➝ Buy
RRC Range Resources	Target Set by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Jiang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.41 -5.6%	$40.00 ➝ $43.00	Equal Weight ➝ Equal Weight
RRGB Red Robin Gourmet Burgers	Upgraded by	CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Wolf Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.08 +34.5%	$10.00	Neutral ➝ Buy
RSI Rush Street Interactive	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.27 -15.2%	$17.00 ➝ $17.00	Buy ➝ Buy
RSI Rush Street Interactive	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chad Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.27 -15.2%	$16.00 ➝ $16.00	Outperform ➝ Outperform
RSI Rush Street Interactive	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Politzer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.27 -15.2%	$14.00 ➝ $15.00	Overweight ➝ Overweight
RVMD Revolution Medicines	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.08 -3.5%	$67.00	Outperform
RVMD Revolution Medicines	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Benjamin Burnett Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.08 -3.5%	$80.00 ➝ $78.00	Buy ➝ Buy
RVMD Revolution Medicines	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ami Fadia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.08 -3.5%	$60.00 ➝ $59.00	Buy ➝ Buy
RYTM Rhythm Pharmaceuticals	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Whitney Ijem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.00 -0.6%	$80.00 ➝ $81.00	Buy ➝ Buy
RYTM Rhythm Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Stringer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.00 -0.6%	$64.00 ➝ $64.00	Buy ➝ Buy
SAND Sandstorm Gold	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tanya Jakusconek Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.24 -2.9%	$6.75 ➝ $7.25	Sector Perform ➝ Sector Perform
SBGI Sinclair	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Cahall Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.87 -4.0%	$19.00 ➝ $17.00	Equal Weight ➝ Equal Weight
SDGR Schrödinger	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Catanzaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.25 +2.5%	$50.00 ➝ $45.00	Overweight ➝ Overweight
SDST Stardust Power	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tate Sullivan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.73 +1.9%	$1.75	Buy
SG Sweetgreen	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dennis Geiger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$45.00 ➝ $35.00	Buy ➝ Buy
SG Sweetgreen	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Tower Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$43.00 ➝ $39.00	Buy ➝ Buy
SG Sweetgreen	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Cho Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$37.00 ➝ $32.00	Neutral ➝ Neutral
SG Sweetgreen	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Charles Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$45.00 ➝ $33.00	Buy ➝ Buy
SG Sweetgreen	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aisling Grueninger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$39.00 ➝ $27.00	Neutral ➝ Neutral
SG Sweetgreen	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Bittner Subscribe to MarketBeat All Access for the recommendation accuracy rating	$23.23 +0.4%	$41.00 ➝ $35.00	Outperform ➝ Outperform
SHOO Steven Madden	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.22 -4.6%	$38.00 ➝ $35.00	Neutral ➝ Neutral
SHOO Steven Madden	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Champine Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.22 -4.6%	$40.00 ➝ $35.00	Hold ➝ Hold
SHOO Steven Madden	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.22 -4.6%	$44.00 ➝ $38.00	Market Perform ➝ Market Perform
SHOO Steven Madden	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Nikic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.22 -4.6%		Hold ➝ Hold
SII Sprott	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Lee Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$60.87 -3.1%	C$67.00 ➝ C$71.00	Buy
SKWD Skyward Specialty Insurance Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Hughes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.21 +2.4%	$54.00 ➝ $61.00	Buy ➝ Buy
SKYT SkyWater Technology	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.13 -10.4%	$12.00 ➝ $12.00	Buy ➝ Buy
SMCI Super Micro Computer	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Wang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.95 -16.0%	$59.00	Equal Weight
SNOW Snowflake	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Schappel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$205.00 ➝ $215.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$190.00 ➝ $200.00	Neutral ➝ Neutral
SNOW Snowflake	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$187.00 ➝ $210.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$210.00 ➝ $215.00	Overweight ➝ Overweight
SNOW Snowflake	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$210.00 ➝ $221.00	Outperform ➝ Outperform
SNOW Snowflake	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%		Neutral ➝ Neutral
SNOW Snowflake	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Blakey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$201.00 ➝ $228.00	Overweight ➝ Overweight
SNOW Snowflake	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$210.00 ➝ $220.00	Overweight ➝ Overweight
SNOW Snowflake	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ki Bin Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$210.00 ➝ $225.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. White Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$188.00 ➝ $230.00	Buy
SNOW Snowflake	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$200.00 ➝ $215.00	Buy ➝ Buy
SNOW Snowflake	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$208.00 ➝ $215.00	Overweight ➝ Overweight
SNOW Snowflake	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ittai Kidron Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$200.00 ➝ $220.00	Outperform ➝ Outperform
SNOW Snowflake	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Lenschow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.78 +4.6%	$190.00 ➝ $203.00	Overweight ➝ Overweight
SNPS Synopsys	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$454.71 -3.3%	$655.00 ➝ $653.00	Overweight ➝ Overweight
SNPS Synopsys	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Quatrochi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$454.71 -3.3%	$540.00 ➝ $520.00	Equal Weight ➝ Equal Weight
SNPS Synopsys	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Charles Shi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$454.71 -3.3%	$650.00 ➝ $650.00	Buy ➝ Buy
SPOK Spok	Upgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Bauser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.94 +2.4%	$15.00 ➝ $20.00	Neutral ➝ Buy
SPT Sprout Social	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.35 -2.6%	$28.00 ➝ $25.00	Sector Perform ➝ Sector Perform
SRE Sempra	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Nicholas Campanella Subscribe to MarketBeat All Access for the recommendation accuracy rating	$71.99 -1.2%	$95.00 ➝ $72.00	Overweight ➝ Equal Weight
SRPT Sarepta Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.06 -3.6%	$75.00 ➝ $75.00	Sell ➝ Sell
SRPT Sarepta Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.06 -3.6%	$202.00 ➝ $202.00	Buy ➝ Buy
SRPT Sarepta Therapeutics	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Abrahams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.06 -3.6%	$165.00 ➝ $161.00	Outperform ➝ Outperform
SSKN STRATA Skin Sciences	Initiated by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Vendetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.64 -1.1%	$6.00	Buy
STAA STAAR Surgical	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$17.69 +3.5%		Hold ➝ Hold
STLD Steel Dynamics	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.32 -0.1%		Underperform ➝ Peer Perform
STRA Strategic Education	Target Lowered by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$79.80 -18.5%	$135.00 ➝ $120.00	Outperform ➝ Outperform
STRL Sterling Infrastructure	Upgraded by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brent Thielman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.15 +0.8%	$185.00	Neutral ➝ Buy
STZ Constellation Brands	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the recommendation accuracy rating	$173.43 -2.8%	$220.00 ➝ $202.00	Overweight ➝ Equal Weight
SYNA Synaptics	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.30 -4.0%	$105.00 ➝ $105.00	Buy ➝ Buy
TASK TaskUs	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Perlin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.45 -7.6%	$18.00 ➝ $20.00	Sector Perform ➝ Sector Perform
TBLA Taboola.com	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.82 -8.7%	$5.00 ➝ $4.00	Buy ➝ Neutral
TBLA Taboola.com	Downgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.82 -8.7%		Outperform ➝ Market Perform
TBLA Taboola.com	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.82 -8.7%	$5.00 ➝ $4.00	Buy ➝ Buy
TCOM Trip.com Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Yao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.20 -2.4%	$80.00 ➝ $75.00	Overweight ➝ Overweight
TDOC Teladoc Health	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.43 -14.2%		Hold ➝ Hold
TDOC Teladoc Health	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.43 -14.2%	$13.00 ➝ $12.00	Overweight ➝ Overweight
TFIN Triumph Financial	Upgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Timothy Switzer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.31 -1.0%	$80.00 ➝ $74.00	Underperform ➝ Market Perform
TFX Teleflex	Downgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$138.99 -21.8%		Outperform ➝ Market Perform
TJX TJX Companies	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Altschwager Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.49 -1.1%	$138.00 ➝ $140.00	Outperform ➝ Outperform
TJX TJX Companies	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.49 -1.1%	$145.00 ➝ $145.00	Outperform ➝ Outperform
TJX TJX Companies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.49 -1.1%	$136.00 ➝ $137.00	Overweight ➝ Overweight
TJX TJX Companies	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$123.49 -1.1%	$133.00 ➝ $145.00	Outperform ➝ Outperform
TKO TKO Group	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Curry Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$151.68 -4.9%	$170.00 ➝ $175.00	Buy ➝ Buy
TKO TKO Group	Reiterated by	Pivotal Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Wlodarczak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$151.68 -4.9%	$145.00 ➝ $195.00	Buy ➝ Buy
TNDM Tandem Diabetes Care	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.75 -35.2%	$65.00 ➝ $55.00	Outperform ➝ Outperform
TNDM Tandem Diabetes Care	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.75 -35.2%	$37.00 ➝ $33.00	Neutral ➝ Neutral
TRIN Trinity Capital	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Paul Johnson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.22 -1.9%	$15.00 ➝ $16.00	Market Perform ➝ Market Perform
TSHA Taysha Gene Therapies	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.59 -1.9%	$6.00 ➝ $6.00	Buy ➝ Buy
TTI TETRA Technologies	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jesse Sobelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.83 -2.7%	$5.50 ➝ $5.50	Buy ➝ Buy
TXRH Texas Roadhouse	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregory Francfort Subscribe to MarketBeat All Access for the recommendation accuracy rating	$177.90 +1.2%	$205.00 ➝ $200.00	Buy ➝ Buy
UHS Universal Health Services	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the recommendation accuracy rating	$185.26 +2.9%	$271.00 ➝ $249.00	Overweight ➝ Overweight
UHS Universal Health Services	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$185.26 +2.9%	$210.00 ➝ $210.00	Equal Weight ➝ Equal Weight
URBN Urban Outfitters	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.25 +8.2%	$56.00 ➝ $59.00	Market Perform ➝ Market Perform
URBN Urban Outfitters	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Altschwager Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.25 +8.2%	$60.00 ➝ $62.00	Neutral ➝ Neutral
URBN Urban Outfitters	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.25 +8.2%	$60.00 ➝ $65.00	Equal Weight ➝ Equal Weight
USNA USANA Health Sciences	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Xue Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.57 -14.0%	$38.00 ➝ $36.00	Neutral ➝ Neutral
USPH U.S. Physical Therapy	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$82.25 -6.2%		Market Perform
UTHR United Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$323.62 +1.5%	$425.00 ➝ $425.00	Buy ➝ Buy
VAC Marriott Vacations Worldwide	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simon Yarmak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$77.40 -9.3%	$112.00 ➝ $108.00	Buy ➝ Buy
VERA Vera Therapeutics	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$29.41 +5.9%	$59.00 ➝ $61.00	Buy ➝ Buy
VIR Vir Biotechnology	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Stringer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.11 -11.8%	$19.00 ➝ $19.00	Buy ➝ Buy
VIV Telefônica Brasil	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andres Coello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.45 -1.5%	$10.40 ➝ $9.20	Sector Perform ➝ Sector Perform
VRSK Verisk Analytics	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$290.11 +0.7%	$298.00 ➝ $320.00	Outperform ➝ Outperform
VRSK Verisk Analytics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$290.11 +0.7%	$325.00 ➝ $321.00	Overweight ➝ Overweight
VRSK Verisk Analytics	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Silber Subscribe to MarketBeat All Access for the recommendation accuracy rating	$290.11 +0.7%	$280.00 ➝ $297.00	Market Perform ➝ Market Perform
VSCO Victoria's Secret & Co.	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Sole Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.85 -5.3%	$47.00 ➝ $34.00	Neutral ➝ Neutral
WBD Warner Bros. Discovery	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Goss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.00 +4.8%	$16.00 ➝ $16.00	Outperform ➝ Outperform
WDAY Workday	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$260.57 -3.9%	$340.00 ➝ $355.00	Sector Outperform ➝ Sector Outperform
WDAY Workday	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the recommendation accuracy rating	$260.57 -3.9%	$300.00 ➝ $314.00	Outperform ➝ Outperform
WLK Westlake	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$110.37 -1.7%	$135.00 ➝ $110.00	Underweight ➝ Neutral
WN George Weston	Downgraded by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Zamparo Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$227.85 -2.8%	C$240.00 ➝ C$241.00	Outperform ➝ Sector Perform
WN George Weston	Target Lowered by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$227.85 -2.8%	C$269.00 ➝ C$268.00	Outperform
WN George Weston	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$227.85 -2.8%	C$266.00 ➝ C$264.00	Outperform
WN George Weston	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$227.85 -2.8%	C$255.00 ➝ C$251.00	Buy
WRBY Warby Parker	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.31 +2.3%	$28.00 ➝ $28.00	Outperform ➝ Outperform
WSO Watsco	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Dankert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$499.55 +0.1%	$450.00 ➝ $460.00	Hold ➝ Hold
WSP WSP Global	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$255.05 -1.5%	C$284.00 ➝ C$294.00
WTRG Essential Utilities	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Reeder Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.65 +0.4%	$39.00 ➝ $41.00	Equal Weight ➝ Equal Weight
XMTR Xometry	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.35 +1.2%	$46.00 ➝ $39.00	Buy ➝ Buy
XPER Xperi	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Frankel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.31 -3.0%	$15.00 ➝ $15.00	Buy ➝ Buy
XPER Xperi	Reiterated by	BWS Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Hamed Khorsand Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.31 -3.0%	$30.00 ➝ $30.00	Top Pick ➝ Top Pick
YOU Clear Secure	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Reilly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.63 +1.8%	$45.00 ➝ $45.00	Buy ➝ Buy
YOU Clear Secure	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.63 +1.8%	$42.00 ➝ $42.00	Outperform ➝ Outperform
YOU Clear Secure	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Kelley Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.63 +1.8%	$32.00 ➝ $26.00	Hold ➝ Hold
ZETA Zeta Global	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.65 -6.3%	$32.00 ➝ $18.00	Equal Weight ➝ Equal Weight
ZI ZoomInfo Technologies	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.01 +2.4%	$10.30 ➝ $11.00	Sector Perform ➝ Sector Perform
ZIMV ZimVie	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Saxon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.88 -1.7%	$23.00 ➝ $23.00	Buy ➝ Buy
ZTS Zoetis	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$164.95 0.0%	$200.00 ➝ $205.00	Overweight ➝ Overweight
ZVIA Zevia PBC	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.23 -2.8%	$4.00 ➝ $3.00	Market Perform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:02 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Stock market today: Asian shares skid, hit by AI doubts and Trump tariff hikes
By The Associated Press | February 27, 2025
View Stock market today: Asian shares skid, hit by AI doubts and Trump tariff hikes
How major US stock indexes fared Thursday, 2/27/2025
By The Associated Press | February 27, 2025
View How major US stock indexes fared Thursday, 2/27/2025
MrBeast's Holding Company Could Be Worth $5 Billion After Its Latest Fundraising Round
By Entrepreneur | February 27, 2025
View MrBeast's Holding Company Could Be Worth $5 Billion After Its Latest Fundraising Round
Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
By Gabriel Osorio-Mazilli | February 27, 2025
View Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
Are We Living in the Golden Age of Day Trading?
By Entrepreneur | February 27, 2025
View Are We Living in the Golden Age of Day Trading?
Nvidia CEO Jensen Huang Says the New ChatGPT Needs '100 Times More' of His Company's AI Chips
By Entrepreneur | February 27, 2025
View Nvidia CEO Jensen Huang Says the New ChatGPT Needs '100 Times More' of His Company's AI Chips
Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings

Top Headlines and Offers

View All

Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings
Archer Aviation Stock Skids: Mistaking Progress for Bad News?
By Chris Markoch | February 24, 2025
View Archer Aviation Stock Skids: Mistaking Progress for Bad News?
30-year market phenomenon opens up overnight opportunity
From ProsperityPub(Ad)
View 30-year market phenomenon opens up overnight opportunity
3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
By Gabriel Osorio-Mazilli | February 21, 2025
View 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
AST SpaceMobile Stock Surges 17% After Analyst Upgrade
By Nathan Reiff | February 26, 2025
View AST SpaceMobile Stock Surges 17% After Analyst Upgrade
Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
By Gabriel Osorio-Mazilli | February 27, 2025
View Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
This Crypto Is Set to Explode in February
From Crypto 101 Media(Ad)
View This Crypto Is Set to Explode in February
Palantir Stock Nears Bear Market Territory - Why and What’s Next?
By Chris Markoch | February 25, 2025
View Palantir Stock Nears Bear Market Territory - Why and What’s Next?
As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
By Chris Markoch | February 21, 2025
View As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
BigBear.ai: Is It Opportunity Knocking or a Trap Door?
By Jeffrey Neal Johnson | February 25, 2025
View BigBear.ai: Is It Opportunity Knocking or a Trap Door?
Palantir Stock Skids—How Much Further Can It Fall?
By Chris Markoch | February 21, 2025
View Palantir Stock Skids—How Much Further Can It Fall?
Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
By Ryan Hasson | February 25, 2025
View Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings